Title : Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases.

Pub. Date : 2015

PMID : 25678799






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases. nab erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 Herein, we report a lengthy progression-free survival with the combination trastuzumab/nanoparticle albumin-bound (nab)-paclitaxel in a heavily pretreated HER2-positive BC patient with BM. nab erb-b2 receptor tyrosine kinase 2 Homo sapiens
3 In conclusion, weekly nab-paclitaxel plus trastuzumab may represent a valuable option in the treatment of HER2-positive MBC with BM after radiotherapy and is effective and associated with a good toxicity profile, even in heavily pretreated patients. nab erb-b2 receptor tyrosine kinase 2 Homo sapiens